Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Gynecologic 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 16Stomach Neoplasms 14Colorectal Neoplasms 13Carcinoma, Non-Small-Cell Lung 10Uterine Cervical Neoplasms 9Ovarian Neoplasms 9Breast Neoplasms 9Neoplasm Metastasis 7Melanoma 7Colonic Neoplasms 7Lung Neoplasms 6Esophageal Neoplasms 6Rectal Neoplasms 5Liver Neoplasms 5Vaginal Neoplasms 4Small Cell Lung Carcinoma 4Penile Neoplasms 4Oropharyngeal Neoplasms 4Gastrointestinal Neoplasms 4Carcinoma, Renal Cell 4Anus Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Endometrial Neoplasms 3Cholangiocarcinoma 3Carcinoma, Hepatocellular 3Vulvar Neoplasms 2Urogenital Neoplasms 2Neoplasms 2Head and Neck Neoplasms 2Gallbladder Neoplasms 2

Interventions

pembrolizumab 3spartalizumab 2trametinib 1tislelizumab 1palbociclib 1nazartinib 1milademetan 1enzalutamide 1devimistat 1dehydroftorafur 1canakinumab 1binimetinib 1bemarituzumab 1aldesleukin 1Specimen Handling 1Pentostatin 1Midazolam 1Methods 1Magnetic Resonance Spectroscopy 1Letrozole 1Interleukin-2 1IFL protocol 1Hydroxychloroquine 1Gemcitabine 1Fulvestrant 1Fluorouracil 1Early Intervention, Educational 1Cyclophosphamide 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma of Lung × aldesleukin × Gastrointestinal × Clear all
NCT05194735 2025-11-10

Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors

Alaunos Therapeutics

Phase 1/2 Terminated
8 enrolled 12 charts
GastrointestinalGynecologicThoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡